rhBMP-2/CPM

Phase 1Completed

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Radius Fractures

Conditions

Radius Fractures

Trial Timeline

Sep 1, 2005 → Jan 1, 2007

NCT ID

NCT00161629

About rhBMP-2/CPM

rhBMP-2/CPM is a phase 1 stage product being developed by Pfizer for Radius Fractures. The current trial status is completed. This product is registered under clinical trial identifier NCT00161629. Target conditions include Radius Fractures.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00384852	Phase 2	Completed	Jan 1, 2007	Feb 1, 2010	Fractures
NCT00161629	Phase 1	Completed	Sep 1, 2005	Jan 1, 2007	Radius Fractures
NCT00243295	Phase 1	Completed	Nov 1, 2003	Mar 1, 2005	Osteoarthritis

Other Products from Pfizer